Vanguard Capital Management’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$195K Hold
233,888
– – ﹤0.01% 3791
2026
Q2
$260K Hold
233,888
– – ﹤0.01% 3797
2026
Q1
$384K Buy
+233,888
New +$564K ﹤0.01% 3715

Other funds holding TPST

Vanguard Capital Management's TPST Position: Q3 2026 in Review

Vanguard Capital Management held its Tempest Therapeutics (TPST) position steady in Q3 2026 at 233,888 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3791.

Vanguard Capital Management first reported a position in TPST in Q1 2026 and has held it in 3 quarters since. The position peaked at $384K in Q1 2026. 24 funds tracked by Wall St. Rank hold TPST as of Q3 2026.

  • Vanguard Capital Management held 233,888 shares of Tempest Therapeutics worth $195K as of Q3 2026.
  • Vanguard Capital Management left its Tempest Therapeutics share count unchanged in Q3 2026.
  • Tempest Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3791 holding.
  • Vanguard Capital Management first reported a position in Tempest Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Tempest Therapeutics position peaked at $384K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.